A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)

Inclusion Criteria: 1. Ability to provide written informed consent. 2. Treated only with the VIVO ISAR stent system. 3. ≥ 18 years old. 4. Male or non-pregnant female patient. 5. Intended for treatment with ≤ 3 months DAPT after PCI as per standard of care. Exclusion Criteria: 1. Patients having any of the following conditions will not be considered (enrolled) for the study Concurrent participation in an interventional study. 2. Cardiogenic shock/hemodynamic instability around the time of the index procedure. 3. Concurrent medical condition with a life expectancy of less than 12 months. 4. Allergy or contraindication to antiplatelet therapy, cobalt chromium, sirolimus or any known hypersensitivity to the planned anti-platelet drugs. 5. History of cerebrovascular accident in the last 6 months. 6. Pregnant female. 7. PCI performed within the previous 3 months from the date of index procedure 8. Treated with another stent type during the index procedure in addition to the VIVO ISAR stent system